BNZL LSE Week ended 07 Aug 2026

Weekly Investor Report

Bunzl plc · Consumer Defensive · Food Distribution

Open interactive chart View report data
Latest close 2,870 GBP
2.4% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 20.4% above the Trend Line and sits at 98.2% of its 52-week range. The latest completed week returned 2.4%, after a 6.8% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high.

Setup score 71 out of 100
Latest Close 2,870 GBP 7 Aug 2026
1W Return 2.4% latest completed week
4W Return 6.8% short-term follow-through
12W Return 23.1% quarterly tape
Trend Breadth 26.9% 14 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • The trend backdrop is active with a 14-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • No major top-level risk cluster is currently dominant.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.4% Latest completed week; four-week move 6.8%. Indicator stack 60/76 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 10 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 20.4% above the Trend Line and sits at 98.2% of its 52-week range. The latest completed week returned 2.4%, after a 6.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8612-week average 0.77

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership10/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.86Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 6.8% over four weeks, 23.1% over 12 weeks, and 28.2% over one year. The current trend has remained active for 14 consecutive weeks.

Performance by holding period

1W2.4%
4W6.8%
12W23.1%
26W40.2%
52W28.2%
Active trend streak14 weeks
Active weeks in one year14
Trend breadth26.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.39Latest activity-pressure read.
Pressure change10.9%Four-week change in activity pressure.
Leadership12.37Latest relative-leadership reading.
RS change29.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Dec 2025 Field coverage 91% Model confidence 72%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength53/100Blend of value, momentum, and quality. Underlying universe rank 48; rank 1 is best.
Value14/100Relative valuation strength. Underlying universe rank 87; rank 1 is best.
Quality87/100Profitability and accounting quality. Underlying universe rank 14; rank 1 is best.
Momentum90/100Medium-term price momentum. Underlying universe rank 11; rank 1 is best.
Growth8/100Revenue and earnings growth. Underlying universe rank 93; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework45/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
20.1x
Price divided by trailing earnings.
Price / sales
0.8x
Market value relative to trailing revenue.
EV / EBITDA
9.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
7.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
28.9%
Gross profit retained from each unit of revenue.
Operating margin
6.4%
Operating profit retained from revenue.
Free-cash-flow margin
7.1%
Free cash flow generated from revenue.
Return on invested capital
11.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
0.6%
Latest one-year revenue growth.
EPS growth
-5.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-1.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.6%
Cash dividends relative to market value.
Buyback yield
2.2%
Net share repurchases relative to market value.
Shareholder yield
4.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 10 relevant articles.

1 positive · 8 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-0.6%Distance below the 52-week high.
13-week volatility2.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher16 of 2610 weeks finished lower.
Best week+6.5%Week of 26 Jun.
Worst week-4.9%Week of 20 Mar.
Latest week+2.4%Week of 7 Aug.

Shape of recent returns

Strong gains7
Modest gains9
Flat weeks0
Modest losses9
Sharp losses1
Recent vol2.7%13-week weekly-return volatility.
Base vol3.0%52-week weekly-return volatility.
Up/down split24/27Count of positive and negative weeks in the 52-week window.
Average skew3.2% / -1.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

IndustryGB Food Distribution
4-week rank1 / 2
Group average3.4%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD50.0%positive activity pressure
RS100.0%positive relative leadership

Four-week leaders

BNZL · LSE6.8%RFG · LSE0.0%
08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape69/100

Trend, activity pressure, participation, and risk combine to a 69/100 tape read.

 Indicator analysis86/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 10/12.

Activity pressure 0.86; No reversal markers Factors60/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 25 SVQF45/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 143.5 of 260 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 10 relevant articles.

Bunzl PLC (BNZL.L) Stock Analysis: Navigating the Consumer Defensive Sector with a 2.58% Dividend Yield Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20262,870 GBP2.4%2,384 GBP2,809 GBP1.3912.374.8MOn
31 Jul 20262,802 GBP1.6%2,357 GBP2,808 GBP1.3910.184.7MOn
24 Jul 20262,758 GBP-1.4%2,333 GBP2,809 GBP1.359.823.5MOn
17 Jul 20262,796 GBP4.0%2,311 GBP2,809 GBP1.3312.773.2MOn
10 Jul 20262,688 GBP-0.1%2,290 GBP2,809 GBP1.269.546.3MOn
3 Jul 20262,690 GBP2.0%2,272 GBP2,810 GBP1.147.67564.8KOn
26 Jun 20262,636 GBP6.5%2,254 GBP2,812 GBP1.087.10815.5KOn
19 Jun 20262,474 GBP-2.5%2,237 GBP2,815 GBP1.081.864.7MOn
12 Jun 20262,538 GBP2.8%2,227 GBP2,818 GBP1.033.252.1MOn
5 Jun 20262,470 GBP4.9%2,216 GBP2,822 GBP1.041.361.3MOn
29 May 20262,354 GBP-1.3%2,211 GBP2,826 GBP1.03-4.048.0MOn
22 May 20262,386 GBP2.3%2,214 GBP2,831 GBP1.02-3.633.9MOn
15 May 20262,331 GBP-1.6%2,215 GBP2,836 GBP1.24-3.816.4MOn
8 May 20262,369 GBP-2.4%2,219 GBP2,842 GBP1.26-3.073.8MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context